Incidence and relative risk of cutaneous squamous cell carcinoma with single-agent BRAF inhibitor and dual BRAF/MEK inhibitors in cancer patients: a meta-analysis | |
Peng, Ling; Wang, Yina; Hong, Yun; Ye, Xianghua; Shi, Peng; Zhang, Junyan; Zhao, Qiong | |
刊名 | ONCOTARGET
![]() |
2017 | |
卷号 | 8期号:47 |
关键词 | BRAF inhibitor MEK inhibitor cuSCC meta-analysis |
ISSN号 | 1949-2553 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3619289 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Peng, Ling,Wang, Yina,Hong, Yun,et al. Incidence and relative risk of cutaneous squamous cell carcinoma with single-agent BRAF inhibitor and dual BRAF/MEK inhibitors in cancer patients: a meta-analysis[J]. ONCOTARGET,2017,8(47). |
APA | Peng, Ling.,Wang, Yina.,Hong, Yun.,Ye, Xianghua.,Shi, Peng.,...&Zhao, Qiong.(2017).Incidence and relative risk of cutaneous squamous cell carcinoma with single-agent BRAF inhibitor and dual BRAF/MEK inhibitors in cancer patients: a meta-analysis.ONCOTARGET,8(47). |
MLA | Peng, Ling,et al."Incidence and relative risk of cutaneous squamous cell carcinoma with single-agent BRAF inhibitor and dual BRAF/MEK inhibitors in cancer patients: a meta-analysis".ONCOTARGET 8.47(2017). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论